CH

Crystal Horizon Investments

North America, Texas, United States, Houston

Description

Crystal Horizon Investments

Investor Profile

Crystal Horizon Investments has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Crystal Horizon Investments frequently co-invest with?

VentureHealth
North America, California, United States, San Jose
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Buttonwood Group Advisors
North America, New York, United States, New York
Co-Investments: 1
Western Life Sciences Venture Fund
North America, Manitoba, Canada, Winnipeg
Co-Investments: 1
The Stevanato Group
Europe, Veneto, Italy, Veneto
Co-Investments: 1
InCube Ventures
North America, California, United States, San Jose
Co-Investments: 1

What are some of recent deals done by Crystal Horizon Investments?

Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series CMay 26, 2015
Amount Raised: $37,100,000